The first nasal vaccine against Covid-19, developed by Bharat Biotech, has received regulator’s nod for conducting Phase 2 and 3 clinical trials, the Department of Biotechnology...
Every batch of Covaxin, the indigenous vaccine against Covid-19 developed by Hyderabad-based Bharat Biotech, undergoes over 200 quality-control tests and then the samples are submitted to...
Hyderabad-based company Bharat Biotech has handed over the data of Phase-3 clinical trial of Covaxin to the government. News agency ANA quoted sources as saying that...
